Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.8%

53 terminated/withdrawn out of 605 trials

Success Rate

85.3%

-1.2% vs industry average

Late-Stage Pipeline

18%

109 trials in Phase 3/4

Results Transparency

25%

78 of 308 completed trials have results

Key Signals

69 recruiting78 with results28 terminated25 withdrawn

Enrollment Performance

Analytics

N/A

261(56.7%)

Phase 4

63(13.7%)

Phase 2

61(13.3%)

Phase 3

46(10.0%)

Phase 1

27(5.9%)

Early Phase 1

2(0.4%)

460Total

N/A(261)

Phase 4(63)

Phase 2(61)

Phase 3(46)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (605)

Showing 20 of 605 trials

NCT06462170Not ApplicableRecruiting

Pancreatic Insulin Production Capacity (PIPC) - a Feasibility Study

Role: lead

NCT04076735Not ApplicableRecruiting

DIFFIR - Geriatric Distal Femur Fixation Versus Replacement

Role: collaborator

NCT02615132Not ApplicableCompleted

TeleRehab for Stroke Patients Using Mobile Technology

Role: lead

NCT05564494Not ApplicableRecruiting

Surgical Treatment of Recurrent Shoulder Dislocations

Role: collaborator

NCT06511258Not ApplicableRecruiting

The STRIVE Before Surgery Trial

Role: lead

NCT07016022Recruiting

Variability and Post-op AEs: Does Preoperative CardioPulmonary Variability Assessment Identify Risk of Postoperative Adverse Events Following Thoracic Surgery

Role: lead

NCT06560957Not ApplicableRecruiting

SYNCED - SYNChronized Eating in Bipolar Depression Study

Role: collaborator

NCT05180994Phase 1Recruiting

Topical Infliximab in Eyes With Penetrating Keratoplasty

Role: collaborator

NCT06935019Not ApplicableEnrolling By Invitation

TRIAGE-GS: Towards Reducing Inefficiencies Affecting Genetics Encounters Through Genome Sequencing

Role: collaborator

NCT04642430Phase 4Recruiting

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Role: lead

NCT05506904Not ApplicableRecruiting

Liberation From Mechanical Ventilation Using Extubation Advisor Decision Support

Role: lead

NCT07536906Not Yet Recruiting

Falls Validation Study

Role: collaborator

NCT06850766Not ApplicableRecruiting

The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma

Role: lead

NCT05754528Phase 4Active Not Recruiting

Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance

Role: lead

NCT05999929Not ApplicableRecruiting

Memory Support System Feasibility Study

Role: collaborator

NCT03249428Not ApplicableEnrolling By Invitation

Cytisine vs Nicotine Replacement Therapy

Role: lead

NCT04812613Enrolling By Invitation

Tobacco-Concurrent Addictions in At-Risk Youth in Ottawa

Role: lead

NCT07097012Phase 4Recruiting

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Role: collaborator

NCT07464080Not ApplicableRecruiting

Advanced Brain Imaging-TKA (fMRI-TKA)

Role: lead

NCT02285816Phase 1Active Not Recruiting

MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours

Role: collaborator